In this section

ICR publications

ICR ImmNet publications feed

Browse all ICR publications

Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7th immunorad conference.

31 December 2025
Stratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic States.

02 April 2025
A Phase I Clinical Trial of Intrahepatic Artery Delivery of TG6002 in Combination with Oral 5-Fluorocytosine in Patients with Liver-Dominant Metastatic Colorectal Cancer.

01 April 2025
Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up from the randomized phase III KEYNOTE-048 study

01 April 2025
Proteogenomic discovery of RB1-defective phenocopy in cancer predicts disease outcome, response to treatment, and therapeutic targets.

28 March 2025
NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth.

17 March 2025
PPP2R1A mutations cause ATR inhibitor sensitivity in ovarian clear cell carcinoma.

17 March 2025
PPP2R1A mutations cause ATR inhibitor sensitivity in ovarian clear cell carcinoma.

17 March 2025
High resolution profiling of cell cycle-dependent protein and phosphorylation abundance changes in non-transformed cells.

16 March 2025
Atezolizumab in High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial.

13 March 2025
CXCL12-Targeted Immunomodulatory Gene Therapy Reduces Radiation-Induced Fibrosis in Healthy Tissues.

04 March 2025
CXCL12-Targeted Immunomodulatory Gene Therapy Reduces Radiation-Induced Fibrosis in Healthy Tissues.

04 March 2025